Nishimura H, Morimoto M, Haniuda M, Masai M, Kobayashi O, Yamanda T, Aoki T, Iida F
Department of Surgery, Shinshu University School of Medicine.
Kyobu Geka. 1992 Jul;45(7):582-5.
We analyzed 91 patients who had curative resection from 1982 to 1989 for stage I and II primary lung cancer. The 5-year survival rates were 71.4% for stage I and 44.7% for stage II. The 5-year survival rates were 86.6% for T 1 N 0 M 0, 47.3% for T 2 N 0 M 0, 56.3% for T 1 N 1 M 0, and 37.9% for T 2 N 1 M 0. There was no cancer death in patients with squamous cell carcinoma of T 1 N 0 M 0. For stage I, tumor diameter was significant factor to influence survival. Although there was a statistically significant difference between stage I and II in patients with adenocarcinoma, there was no significant difference in those with squamous cell carcinoma. Chemotherapy had no significant improvement in survival for stage I and II lung cancer.
我们分析了1982年至1989年间因I期和II期原发性肺癌接受根治性切除术的91例患者。I期患者的5年生存率为71.4%，II期为44.7%。T1N0M0的5年生存率为86.6%，T2N0M0为47.3%，T1N1M0为56.3%，T2N1M0为37.9%。T1N0M0鳞状细胞癌患者无癌症死亡。对于I期，肿瘤直径是影响生存的重要因素。虽然腺癌患者I期和II期之间存在统计学显著差异，但鳞状细胞癌患者无显著差异。化疗对I期和II期肺癌的生存率无显著改善。
